Ivabradine and Outcomes in Chronic Heart Failure (SHIFT): A Randomised Placebo-Controlled Study
Chronic heart failure affects roughly 2–3% of the population in many industrialised countries.
Chronic heart failure affects roughly 2–3% of the population in many industrialised countries.